A Randomized, Open-label, Single-Dose, 2-Treatment, 2-Way, 2-Period Crossover Study to Compare the Safety and the Pharmacokinetic Characteristics of Mosapride/Rebamipide Combination Tablet with Mosapride and Rebamipide Tablet in Healthy Male Korean Subjects
Latest Information Update: 18 Sep 2019
At a glance
- Drugs Mosapride/rebamipide (Primary) ; Mosapride; Rebamipide
- Indications Dyspepsia
- Focus Pharmacokinetics
- 25 Aug 2016 New trial record